PHILADELPHIA — (July 19, 2023) — Scientists have long used community advisory boards to engage communities and provide feedback on studies, but this model has limitations. Now, researchers from The…
Philadelphia—For the first time since 2019, The Wistar Institute opened its doors to host, in person, the 27th annual Jonathan Lax Memorial Award Lecture, which featured Deborah Persaud, M.D., Prof…
PHILADELPHIA—(June 22, 2023)—The Wistar Institute hosts its 27th Jonathan Lax Memorial Lecture Thursday, June 29th at 5:30 pm EST. For the first time since 2019, the signature event will be hosted …
PHILADELPHIA — (June 20, 2023) — When cancer that starts in the body metastasizes to the brain, it is almost always lethal, in part because so few treatment options exist. Now a new study by Wistar…
PHILADELPHIA — (May 26, 2023) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Sozi Tulante to its Board of Trustee…
PHILADELPHIA — (May 10, 2023) — GeneOne Life Science, Inc.(“GeneOne” KOSPI: 011000), a leading biopharmaceutical company specializing in developing nucleic-acid based treatments and novel small-mol…
PHILADELPHIA — (MAY 9, 2023) — The Wistar Institute has formed a new strategic collaboration with the Pennsylvania Biotechnology Center (PABC) and the Baruch S. Blumberg Institute to accelerate the…
PHILADELPHIA — (MAY 4, 2023) — The p53 gene is one of the most important in the human genome: the only role of the p53 protein that this gene encodes is to sense when a tumor is forming and to kill…
PHILADELPHIA — (MARCH, 30, 2023) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Squire Servance, founder and mana…
PHILADELPHIA — (MARCH 28, 2023) — As of 2022, approximately 1.2 million people in the United States are living with HIV. Antiretroviral therapies have enabled many of these individuals to live prod…
